Company: REVB
Filing Date: 2025-05-20
Form Type: S-1
Source: 0001213900-25-045828
Chunk: 47

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-20
Form: S-1
Chunk 47
---
. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, some courts both within and outside the United States may be less willing, or unwilling, to protect trade secrets. If a competitor lawfully obtained or independently developed any technology or information that we protect as trade secret, we would have no right to prevent such competitor from using that technology or information to compete with us, which could harm our competitive position. Intellectual property rights do not necessarily address all potential threats. The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations and may not adequately protect our business or permit us to maintain our competitive advantage. For example:

| ● | others may be able to make products that are similar to our                                                                             
 Program Products and any future product candidates we may develop but that are not covered by the claims of the patents that we may own 
 or license in the future;                                                                                                               |

| ● | we, or our future collaborators, might not have been the                                                                             
 first to make the inventions covered by the issued patents and pending patent applications that we may own or license in the future; |

| ● | we, or our future collaborators, might not have been the                       
 first to file patent applications covering certain of our or their inventions; |

| ● | others may independently develop similar or alternative technologies                                        
 or duplicate any of our technologies without infringing our owned or licensed intellectual property rights; |

| ● | it is possible that our pending patent applications or those      
 that we may file in the future will not result in issued patents; |

| ● | patents that we may own or license in the future may be held                            
 invalid or unenforceable, including as a result of legal challenges by our competitors; |

| ● | our competitors might conduct research and development activities                                                                        
 in countries where we do not have patent rights and then use the resulting information to develop competitive products for sale in major 
 commercial markets in which we do not have sufficient patent rights to stop such sales;                                                  |

| ● | we may not develop additional proprietary technologies that 
 are patentable;                                             |

| ● | third-party patents may be asserted against our product candidates     
 and technologies in a manner that threatens or harms our business; and |

| ● | we may choose not to file a patent application in order to                                                                            
 maintain certain trade secrets or know-how, and a third party may subsequently file a patent covering such trade secrets or know